Literature DB >> 9009136

Morbidity of chronic hepatitis C as seen in a tertiary care medical center.

D H Lee1, H Jamal, F G Regenstein, R P Perrillo.   

Abstract

We studied the morbidity of chronic hepatitis C in patients referred to a tertiary care medical facility. The medical records of 500 consecutive cases of chronic hepatitis C were examined for the following: (1) source and time of exposure, (2) signs and symptoms of liver disease, (3) degree of alcohol intake, (4) liver biopsy findings, (5) extrahepatic disease manifestations, and (6) coexisting illnesses that could have an impact on morbidity. Morbidity and histologic findings were evaluated in relation to the duration of hepatitis C. The onset of infection could be determined in 376 patients (75%). A close relationship between the length of infection and disease features was not observed. Fatigue was common at all stages of infection. Whereas cirrhosis occurred more frequently in patients with disease of long duration, 15-24% of patients had signs of advanced liver disease (ascites, encephalopathy, thrombocytopenia) within six years of exposure. Overt extrahepatic manifestations of chronic hepatitis C occurred infrequently, and depression was reported in 24% of untreated patients. In conclusion, in patients referred to a tertiary care setting, chronic hepatitis C is often associated with significant morbidity.

Entities:  

Mesh:

Year:  1997        PMID: 9009136     DOI: 10.1023/a:1018818012378

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

Review 1.  Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features.

Authors:  J L Dienstag
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

2.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

3.  Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

Authors:  S Fargion; A Piperno; M D Cappellini; M Sampietro; A L Fracanzani; R Romano; R Caldarelli; R Marcelli; L Vecchi; G Fiorelli
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

4.  Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.

Authors:  A M Di Bisceglie; Z D Goodman; K G Ishak; J H Hoofnagle; J J Melpolder; H J Alter
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

5.  Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score.

Authors:  S H Caldwell; X Li; R M Rourk; A Millar; K M Sosnowski; M Sue; A S Barritt; R W McCallum; E R Schiff
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

6.  Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119)

Authors:  C L Mendenhall; L Seeff; A M Diehl; S J Ghosn; S W French; P S Gartside; S D Rouster; Z Buskell-Bales; C J Grossman; G A Roselle
Journal:  Hepatology       Date:  1991-10       Impact factor: 17.425

7.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

Authors:  K Yoshioka; S Kakumu; T Wakita; T Ishikawa; Y Itoh; M Takayanagi; Y Higashi; M Shibata; T Morishima
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

8.  Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

Authors:  L B Seeff; Z Buskell-Bales; E C Wright; S J Durako; H J Alter; F L Iber; F B Hollinger; G Gitnick; R G Knodell; R P Perrillo
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

9.  Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

Authors:  F Lunel; L Musset; P Cacoub; L Frangeul; P Cresta; M Perrin; P Grippon; C Hoang; D Valla; J C Piette
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

10.  High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests.

Authors:  H Gray; T Wreghitt; I M Stratton; G J Alexander; R C Turner; S O'Rahilly
Journal:  Diabet Med       Date:  1995-03       Impact factor: 4.359

View more
  12 in total

1.  Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Jeffrey Samet
Journal:  AIDS Care       Date:  2012-01-24

2.  Major depressive disorder in hepatitis C: an open-label trial of escitalopram.

Authors:  Ondria C Gleason; William R Yates; Michelle A Philipsen
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems.

Authors:  Howard Libman; Richard Saitz; David Nunes; Debbie M Cheng; Jessica M Richardson; John Vidaver; Julie K Alperen; Jeffrey H Samet
Journal:  Am J Gastroenterol       Date:  2006-06-16       Impact factor: 10.864

4.  Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.

Authors:  Charles L Raison; Andrey S Borisov; Sherry D Broadwell; Lucile Capuron; Bobbi J Woolwine; Ira M Jacobson; Charles B Nemeroff; Andrew H Miller
Journal:  J Clin Psychiatry       Date:  2005-01       Impact factor: 4.384

5.  Psychological impact of chronic hepatitis C: comparison with other stressful life events and chronic diseases.

Authors:  Laurent Castera; Aymery Constant; Pierre-Henri Bernard; Victor de Ledinghen; Patrice Couzigou
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

6.  The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection.

Authors:  S Barrett; J Goh; B Coughlan; E Ryan; S Stewart; A Cockram; J C O'Keane; J Crowe
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 7.  Central nervous system involvement in hepatitis C virus infection.

Authors:  Daniel M Forton; Howard C Thomas; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

8.  Neuropsychiatric complications after liver transplantation: role of immunosuppression and hepatitis C.

Authors:  Claudio R Tombazzi; Bradford Waters; M Hosein Shokouh-Amiri; Santiago R Vera; Caroline A Riely
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

9.  Role of Sleep Disturbance in Chronic Hepatitis C Infection.

Authors:  Meghan D Carlson; Robin C Hilsabeck; Fatma Barakat; William Perry
Journal:  Curr Hepat Rep       Date:  2010-02-20

10.  Mode of transmission, rather than the hepatitis C virus, as a major determinant of poor interpersonal relationships in patients with chronic hepatitis C.

Authors:  T P LA; M Deschênes
Journal:  Can J Gastroenterol       Date:  2007-12       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.